Product Details:
Payment & Shipping Terms:
|
Source: | Yeast | Molecular Weight: | 9.1kD |
---|---|---|---|
Formulation: | RhIGF-1 LR3 Is Lyophilized With Mannitol As The Stabilizer | Endotoxin: | Less Than 5.0 EU/mg |
Usage: | Cell Culture, Stem Cell Culture, Vaccine Research | Storage And Handling: | -20℃ For 24 Months |
Highlight: | Yeast Origin Recombinant IGF 1 Long R3,Recombinant IGF 1 Long R3 Lyophilized,Yeast rhIGF-1 LR3 |
Yeast Origin Recombinant IGF 1 Long R3 Lyophilized Greater Than 90% Purity For Serum - Free Medium
Description
Serum-free media and reagents are widely used in mammalian cells culture and produce monoclonal antibodies, viral antigens and recombinant proteins. So we have extramely high requirements to raw materials in the formula. rhIGF-1 LR3 produced by Healthgen Bichtech is extracted from rice grain endosperm cells. It avoids the risk of virus pollution in human-origin ingredients or bacterial fermentation and reduces the probability of production and experimental problems.
Quick Details
Product Name | Recombinant Insulin-Like Growth Factor 1, LR3 |
Source | Yeast |
Catalog No. | HYC007M01 |
Physical Appearance | White lyophilized powder |
Formulation | rhIGF-1 LR3 is lyophilized with saline. |
Purity | >90% |
Endotoxin | Less than 5.0 EU/mg |
Restrictions | FOR RESEARCH, LABORATORY AND MANUFACTURE USE ONLY. NOT INTENDED FOR DIRECT USE ON HUMANS. |
Advantages
1. Healthgen Biotech rhIGF-1 LR3 has excellent batch consistency. Using self-pollination rice as the bioreactor to express the rhIGF-1 LR3 with the world's advanced facility and top production proceeding to extract and purify the rhIGF-1 LR3, Healthgen Biotech can ensure the excellent consistency of rhIGF-1 LR3 from different batches.
2. The rice endosperm specific expression platform is easy to be large-scale. The rice endosperm has the protein body, which can keeps proteins stability and bioactivity. At present, the production capacity is almost 1 kg / year.
3. Healthgen Biotech has a professional quality control department, in which 50% of them have master's degree or higher. There are 14 employees in the quality department, 9 of them are in QA and 5 are in QA. All of them have rich experience in analysis research or quality inspection. Half of them have graduated diploma. Every year there are more than 50 training courses, which cover GMP, SOP, specification, hygiene, QA, QC issues, etc.
Supplemental Description
Healthgen Biotech has strong technical force and advanced and complete protein expression and purification technology development and large-scale production facilities. Self-developed rice endosperm cell expression platform (OryzHiExp), which is domestic initiative and the international leader, has such advantages: high expression level, safety, scale-up easily, simple production process and environmental protection etc. After 10 years of unremitting efforts, Healthgen Biotech has established recombinant protein expression and purification technology platform to customize recombinant protein or peptide expression and purification process service for pharmaceuticals, health products, scientific research and industrial reagents. Using the OryzHiExp platform, Healthgen Biotech has achievements in developing and commercializing a series of medium ingredients, including recombinant human serum albumin(OsrHSA), recombinant α-1 antitrypsin(OsrhAAT), recombinant human lactoferrin(OsrhLF), recombinant human basic fibroblast growth factor (OsrhbFGF), recombinant human insulin-like growth factor-1 LR3(rhIGF-1 LR3) , recombinant human epidermal growth factor(rhEGF) and recombinant human fibronectin(OsrhFN), which can provide a full set of solutions for animal component free cell culture medium.
Contact Person: Ms. Abby
Tel: +86-15071115810
Fax: 86-27-59403933-59416006